Search research articles
Contact Us
Filters
Showing results (11-20 of 189) with videos related to
Page
of 19
Sort By:
Marine Drugs
|
October 16, 2010
New one-pot methodologies for the modification or synthesis of alkaloid scaffolds
Amir E Wahba, Mark T Hamann
Journal of Food Protection
|
April 3, 2019
Survival of Streptococcus thermophilus and Lactobacillus bulgaricus in Commercial and Experimental Yogurts
William T Hamann, Elmer H Marth
Journal of Natural Products
|
June 1, 1996
Keenamide A, a bioactive cyclic peptide from the marine mollusk Pleurobranchus forskalii
K J Wesson, M T Hamann
The Journal of Organic Chemistry
|
April 10, 2012
Reductive N-alkylation of nitroarenes: a green approach for the N-alkylation of natural products
Amir E Wahba, Mark T Hamann
Development (Cambridge, England)
|
March 9, 1999
The auxin-insensitive bodenlos mutation affects primary root formation and apical-basal patterning in the Arabidopsis embryo
T Hamann, U Mayer, G Jürgens
Behavioral Sciences (Basel, Switzerland)
|
June 26, 2026
Poemas de la Pradera: Transnational Identity Development Through YPAR and AI-Assisted Mayan Language Preservation
Hector Palala Martinez, Edmund T Hamann
Journal of Natural Products
|
November 27, 2001
Isolation and biological evaluation of filiformin, plakortide F, and plakortone G from the Caribbean sponge Plakortis sp
D J Gochfeld, M T Hamann
Bioorganic & Medicinal Chemistry
|
August 16, 2011
In vitro and in vivo evaluation of select kahalalide F analogs with antitumor and antifungal activities
Abbas Gholipour Shilabin, Mark T Hamann
Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP
|
August 6, 2002
Marine pharmacology in 1999: compounds with antibacterial, anticoagulant, antifungal, anthelmintic, anti-inflammatory, antiplatelet, antiprotozoal and antiviral activities affecting the cardiovascular, endocrine, immune and nervous systems, and other miscellaneous mechanisms of action
Alejandro M S Mayer, Mark T Hamann
Marine Biotechnology (New York, N.Y.)
|
October 30, 2003
Marine pharmacology in 2000: marine compounds with antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiplatelet, antituberculosis, and antiviral activities; affecting the cardiovascular, immune, and nervous systems and other miscellaneous mechanisms of action
Alejandro M S Mayer, Mark T Hamann
Page
of 19
Search research articles
Search
Showing results (11-20 of 189) with videos related to
Sort By:
Page
of 19
Marine Drugs
|
October 16, 2010
New one-pot methodologies for the modification or synthesis of alkaloid scaffolds
Amir E Wahba, Mark T Hamann
Journal of Food Protection
|
April 3, 2019
Survival of Streptococcus thermophilus and Lactobacillus bulgaricus in Commercial and Experimental Yogurts
William T Hamann, Elmer H Marth
Journal of Natural Products
|
June 1, 1996
Keenamide A, a bioactive cyclic peptide from the marine mollusk Pleurobranchus forskalii
K J Wesson, M T Hamann
The Journal of Organic Chemistry
|
April 10, 2012
Reductive N-alkylation of nitroarenes: a green approach for the N-alkylation of natural products
Amir E Wahba, Mark T Hamann
Development (Cambridge, England)
|
March 9, 1999
The auxin-insensitive bodenlos mutation affects primary root formation and apical-basal patterning in the Arabidopsis embryo
T Hamann, U Mayer, G Jürgens
Behavioral Sciences (Basel, Switzerland)
|
June 26, 2026
Poemas de la Pradera: Transnational Identity Development Through YPAR and AI-Assisted Mayan Language Preservation
Hector Palala Martinez, Edmund T Hamann
Journal of Natural Products
|
November 27, 2001
Isolation and biological evaluation of filiformin, plakortide F, and plakortone G from the Caribbean sponge Plakortis sp
D J Gochfeld, M T Hamann
Bioorganic & Medicinal Chemistry
|
August 16, 2011
In vitro and in vivo evaluation of select kahalalide F analogs with antitumor and antifungal activities
Abbas Gholipour Shilabin, Mark T Hamann
Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP
|
August 6, 2002
Marine pharmacology in 1999: compounds with antibacterial, anticoagulant, antifungal, anthelmintic, anti-inflammatory, antiplatelet, antiprotozoal and antiviral activities affecting the cardiovascular, endocrine, immune and nervous systems, and other miscellaneous mechanisms of action
Alejandro M S Mayer, Mark T Hamann
Marine Biotechnology (New York, N.Y.)
|
October 30, 2003
Marine pharmacology in 2000: marine compounds with antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiplatelet, antituberculosis, and antiviral activities; affecting the cardiovascular, immune, and nervous systems and other miscellaneous mechanisms of action
Alejandro M S Mayer, Mark T Hamann
Page
of 19